Zolpidem Tartrate Tablet, Coated
Product Images NDC 0781-5317

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 0781-5317). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zolpidem 01

Zolpidem 01
Chemical structure of Zolpidem Tartrate, showing the molecular arrangement of the active ingredient in this human prescription drug.*
FDA Label Image

Zolpidem 02

Zolpidem 02
Zolpidem Tartrate Tablets USP 5 mg oral coated tablets label by Sandoz Inc. The label shows 30 tablets with NDC 0781-5317-31. It includes dosage and storage instructions, pharmacist dispensing guidance, and manufacturing information indicating the product is made in India by Lek Pharmaceuticals for Sandoz Inc.*
FDA Label Image

Zolpidem 03

Zolpidem 03
Label for Zolpidem Tartrate Tablets, USP 10 mg by Sandoz Inc. The label states the product contains 30 coated tablets for oral use and includes an NDC number 0781-5318-31. It shows the strength as 10 mg, a Schedule IV control symbol, storage info, pharmacist dispensing instructions, and imprint area with 2D barcode space, lot, and expiration date fields.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.